<DOC>
	<DOCNO>NCT01226914</DOCNO>
	<brief_summary>Primary Objectives - To compare amount post-operative wound drainage group patient EVICEL™ spray utilize ( Arm A ) , group patient EVICEL™ placebo utilized ( Arm B ) . - To compare length time drain removal Arm A Arm B . Secondary objectives - To compare incident rate seroma , hematoma , post-operative edema two group . - To compare report pain experienced group select time point use standard numerical rating scale ( NRS ) . - To compare length hospital stay two group patient .</brief_summary>
	<brief_title>A Trial Comparing Wound Drainage Post-operative Complications With Without Use EVICEL™ Fibrin Sealant Thyroidectomy</brief_title>
	<detailed_description />
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Inclusion Criteria Patients must initial diagnosis thyroid neoplasmcarcinoma goiter require total hemithyroidectomy . Patients must ECOG performance status 02 Laboratory value must within follow range : Platelet count &gt; 100 k/mm3 Hemoglobin &gt; 10.0 g/dL WBCs &gt; 3.0 k/mm3 Total bilirubin &lt; 2.6 Serum Creatinine &lt; 2.0 PTT PT/INR within institutional normal limit Patients must sign informed consent study participation Exclusion Criteria Evidence distant metastasis thyroid carcinoma Recurrent thyroid cancer Prior thyroid surgery surgery neck . Patients diagnosed coagulation disorder Prior irradiation neck area Prior chemotherapy current diagnosis Patients therapeutic warfarin Patients psychological cognitive issue , opinion investigator , make unable adequately report pain level Patients immune deficient state</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>EVICEL , Fibrin Sealant , Thyroidectomy</keyword>
</DOC>